Anp-dependent antibodies

TW202631669APending Publication Date: 2026-08-01LANOVA MEDICINES LTD CO
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Filing Date
2025-01-22
Publication Date
2026-08-01

Smart Images

  • Figure TWG2TA001069747_001
    Figure TWG2TA001069747_001
  • Figure TWG2TA001069747_002
    Figure TWG2TA001069747_002
  • Figure TWG2TA001069747_003
    Figure TWG2TA001069747_003
Patent Text Reader

Abstract

Provided are antibodies capable of binding an antigen in an adenine nucleotide-dependent manner. Examples of adenine nucleotides include ATP, ADP and AMP, which are frequently present in tumor microenvironment at much higher concentrations in normal tissues. Such antibodies, if designed to target a tumor associated antigen or immune checkpoint molecule, can target tumor tissues more specifically than conventionally antibodies and thus have improved therapeutic index.
Need to check novelty before this filing date? Find Prior Art